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Abstract
For the purpose to study in vivo changes of the mice bearing Ehrlich ascites tumor with special
emphasis on the problems of cellular antibody and serum antibody, a series of experiments such as
neutralization tests in vivo and in vitro study of the effect of lymph-node cells from the tumor bear-
ing animals on target cells were carried out, and the findings thus obtained are briefly summarized
as follows : 1. Regional lymph-node cells from the mouse transplanted with Ehrlich ascites tumor
cells show a marked cytotoxic action on their cultured target cells, JTC-11, synergistically with
serum from mouse bearing Ehrlich cancer. 2. The tumor cells inoculated with lymph-node cells
from the tumor bearing animals showed a retardation in growth and finally regressed. 3. Spleen
and lymph nodes of tumor bearing animals showed a marked increase in weight.
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In the previous papers1,2 it was demonstrated that the lymphoid cells from
the mice bearing Ehrlich cancer inhibit the proliferation of target cells in vitro
and that. it is necessary for these cells to come in contact with the target cells in
order to wield a sufficient inhibitory effect on the proliferation. Consequently,
it was assumed that the antibodies are adhered to the surface of these lymphoid
cells. It is known3 that aside from the antibody bound to these lymphoid cells
the serum antibody also plays an important role in the inhibition of tumor growth.
However, there is a report· to the contrary that the serum antibody weakens
the ability of the cellular antibody, bringing about an enhancement of tumor
proliferation, and also another opinion5 that the survival of the tumor transplant,
which is destined to be discarded by the host, is prolonged by the serum anti-
body. Therefore, there still remain many unsolved problems about the relation-
ship between the cellular antibody and the serum antibody. For the purpose to
clarify these problems the following experiments were conducted: 1) to see the
effect of the cellular antibody to which serum antibody was bound previously in
vitro on target cells; 2) to see whether or not the lymphoid cell that showed
anti-tumor effect in vitro would also reveal the same effect in vivo; and 3) to
see changes in the weights of various organs in vivo weekly after the tumor
transplantation.
MATERIALS AND METHODS
The male adult mice of Cb strain, 4 weeks old, were used. They were
fed on solid food MF (Oriental Yeast Co. ) with fresh vegetables. These mice
received the transplantation of Ehrlich ascites tumor cells subcutaneously to the
total of 5 X 106 each in between the shoulder bones and scapula on both sides.
After 14 days the animals belonging to the first group were sacrificed by decapi-
tationand the lymph nodes of axillary and cervical regions were obtained.
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These lymph nodes were then broken into small. pieces with ophthalmic scissors
in cold Hanks solution, centrifuged at 1,000 rpm for 10 minutes, 3 times each,
and the sediment so obtained served as the lymph-node cells from "sensitized"
animals. Other animals served as control, and without any pretreatment the
lymph nodes from the similar regions as in the former group were obtained and
the lymph-node cells were prepared in the same fashion as just mentioned. The
animals belonging to the second group were inoculated with the tumor cells as
in those of the first group. The blood was obtained by heart pucture two
weeks after the tumor inoculation. The serum was separated by centrifugation,
inactivated by being heated at 56°C for 30 minutes and used for the test of
antitumor activity. In the test, fresh guinea-pig serum served as the comple-
ment. It was used after being absorbed by washed, packed spleen cells of mouse
at 4°C for one hour. To determine the antitumor effect of mouse-antiserum,
following MbLLER's method6, the mixture of O. 05 ml cell suspension containing
1 X 107 JTC-ll cells/ml of medium and 0.05 ml guinea-pig serum was incubated
at 37°C for 90 minutes, and after staining by SCHREK'S method the number of
stained cells was taken for this purpose. The culture medium was YLE solution
containing 2096 bovine serum. The target cells used in tissue culture were a
substrain of Ehrlich cancer cells (JTCll, SATO). For the test of antitumor
activity of the lymph-node cells, 2 X 10· of the tumor cells were cultured with
4 X 106 lymph-node cells. And both antiserum and complement were used in
the proportion of O. 12 ml each for each 1. 5 ml of the culture medium. After
incubating for 24 or 48 hours at 37°C, the cell counts were taken by KATSUDA'S
method7, which is a modification of SUNFORD'S principle, and the average
number from 3-4 culture vessels was recorded.
For the determination of living cell number the so-called "unstained cell
count method" of SCHREK was used, i. e. by the supravital staining with 1%
Esosin-Y solution the living cell numbetwas calculated by subtracting the stained
cell number from the whole cell number and it was used for lymph-node cells.
As for determining the anti-tumor effect of lymph-node cells in vivo, the
cell mixture of 5 X 104 Ehrlich ascites tumor cells and 5 X 106 lymph-node cells
was immediately transplanted subcutaneously on the back of mice.
In addition, for the puropose to pursue in vivo changes after the implanta-
tion of tumor cells such organs as liver, kidneys, spleen, lungs, thymus and
axillary lymph nodes were taken out of mice. Once every week for the period
of four weeks their weights were compared with respective organs obtained
from non-sensitized groups of mice. In this instance, organ enlargement assay
was represented by the percentage of body weight according to the method of
SIMONSEN and others8•
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RESULTS
The blood serum obtained from the animals two weeks after the tumor
inoculation showed a slight antitumor activity, i.e. by incubating for 90 minutes
18 per 300 tumor cells were stained with Eosin-Y stain, showing 6% cytotoxic
titer, while the titer with the serum from control animals proved to be 0%. In
the cell culture with addition of antiserum some anti-tumor effect was observed,
but when lymph-node cells were further added to such a culture, a marked anti-
tumor effect was observed (Fig. 1).
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Fig. 1 Growing Curve of the ]TC-ll Cells Cultured with or without Lymph-node Cells
and Serum.
A: control without lymph-node cells and serum B: cultured with lymph-node
cells from control mice C: cultured with lymph-node cells from sensitized animals.
D: cultured with the serum from tumor bearing animal. E: cultured with serum
from tumor bearing animals and lymph-node cells from control mice. F: cultured
with serum and lymph-node cells from turnor bearing animals. Method: see text.
In the in vivo experiment the tumor formation after the implantation with
lymph-node cells from tumor bearing animal was delayed and tumors themselves
did not grow much in contrast to that with non-sensitized ones, but later they
became smaller, showing regression (Fig. 2). On the 28th day after implantation
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Fig. 2 Growth of Ehrlich Cancer Inoculated with Lymph-node Cells on
the Back of Mice.
A: control group with lymph-node cells from non-sensitized ani-
mals. B: experimental group with lymph-node cells from tumor-
bearing animals. Method: see text.
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Fig. 3 Changes in Organ Weight after Tumor Inoculation (organ
enlargement assay).
Ly: lymph-node S: spleen Li: liver K: kidney Lu:
lung T: thymus Method: see text.
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the weight of tumors transplanted with the lymph-node cells from tumor bearing
animal was 0.061 g in the mean vaiue while it was 0.565 g in the control.
The organs of the tumor bearing mice showed an increase in weight, espe-
cially in spleen and lymph nodes (Fig. 3).
DISCUSSION
From the experiments of ALGIRE and his co-workers!l using the diffusion
chamber and those of BILLINGHAM and otherslO in which they did passive transfer
with serum, the consensus of opinions is that antiserum-antibody is not concerned
with homotransplantation. However, GORER and his colleagues11.l2 reported that
a specific antibody could be detected in the serum of the mouse that rejected
tumor homograft. MITCHISONlS, WINN and othersl4 have also observed these
phenomena. By the present experiments in Cb mice transplanted with Ehrlich
cancer cells there has been observed a serum antibody that shows 6% cytotoxic
titer, and this, according to HELLSTROMll" would fall within the limit of experi-
mental error. Furthermore, in view of 0% cytotoxic titer of non-sensitized
serum, it seems to be reasonable to assume the presence of serum antibody.
According to AKIYAMAl8 it is said that in the mice inoculated with AH39 cells
anti-transplantability of serum commences to increase within about one week
after antigenic stimulation, reaching its maximum around the second week, and
thereafter the titer persists for a long period of time. In the present experiments
the serum obtained in the second week after implantation of Ehrlich ascites
tumor was likewise used as antiserum.
As for the realtionship between serum-antibody and cellular antibody there
are opinions that cellular antibody is formed by serum-antibody becoming atta-
ched to cellsJ7• On the other hand, in the phase microscopic observations of the
reaction between SCI leukemic cells and sensitized lymphocytes, HANAOKA18 has
demonstrated the presence of cellular antibody on the surface of sensitized
lymphocytes. He claims that this cellular antibody is present in 195 fraction
and it is different from the serum antibody contained in 75 fraction and therefore
is an independent one.
Furthermore, AKIYAMAl8 has concluded on the study of Yoshida sarcoma
that serum antibody and cellular antibody are different and independent from
each other. The fact that lymph-node cells in the presence of antiserum, irres-
pective of whether they were previously sensitized or not, show a similar inhi-
bitory effect on target cells, as observed in the present experiments, seems to
indicate that this antiserum also contains a certain cytophilic antibody. As for
the fresh guinea-pig serum to be used as a complement, since it loses its toxicity
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against mouse cells when it is either absorbed by mouse tissue or by being
heated at 56°C for 20 minutes according to SCHLESINGER19, in the present experi-
ments the fresh guinea-pig serum was made to be absorbed by washed, packed
spleen cells of the mouse at 4°C for one hour' before the use.
Next, among those who have observed the effect of sensitized lymphoid
cells in vivo, there is an extensive study by WINN20• In his neutralization ex-
periment where the combination of Sal and the sensitized lymph-node cells from
Sal-susceptible mouse is injected to the isogenetic mouse, he has observed that
there is no appreciable change in the size of tumors developed whether the
mixture of sensitized lymphnode cells and Sal is or not incubated prior to injec-
tion; that the greater the number. of sensitized lymph-node cells challenging
against Sal the longer is the survival of recipient mouse; and that even when
there is no appreciable difference in the survival time, the weight of tumor
extracted at a fixed time shows a definite relationship between the inhibitory
effect on tumor proliferation and the number of lymph-node cells. KIDD and
others21 have demonstrated that when the homogenate of the lymph nodes from
the mouse previously removed of its regressive lymphoma is inoculated to the
cells from the mouse susceptible to lymphoma and incubated in vitro for 1-2
hours, tumor cell proliferation is inhibited.
Since Ehrlich ascites tumor used is a non-specific tumor, when it is trans·
planted to the mouse susceptible to it, tumor develops but when the number of
cells transplanted is small, it gradually shows regression. However, in the
neutralization tests in vivo there can be seen distinct differences in the action
behaviors of sensitized lymph-node cells and of non-snesitized ones on recipient
tissues.
Finally, it has been observed that along with the proliferation of tumors in
the recipient, the function of the reticula-endothelial system is accelerated,
making the weight of spleen and lymph nodes markedly heavier. This is an
intresting phenomenon when compared with the increase in immunologically
competent cells as described in a previous paper2• As has been stated by
SIMONSEN4 in the transplantation of tumor to animals, the younger the host the
greater is the gain in the weight of organs of the recipient.
SUMMARY
For the purpose to study in vivo changes of the mice bearing Ehrlich ascites
tumor with special emphasis on the problems of cellular antibody and serum
antibody, a series of experiments such as neutralization tests in vivo and in
vitro study of the effect of lymph-node cells from the tumor bearing animals on
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target cells were carried out, and the findings thus obtained are briefly summa-
rized as follows :
1. Regional lymph-node cells from the mouse transplanted with Ehrlich
ascites tumor cells show a marked cytotoxic action on their cultured target cells,
JTC-ll, synergistically with serum from mouse bearing Ehrlich cancer.
2. The tumor cells inoculated with lymph-node cells from the tumor
bearing animals showed a retardation in growth and finally regressed.
3. Spleen and lymph nodes of tumor bearing animals showed a marked
increase in weight.
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